NEW YORK IBM and its Watson cloud computing system are partnering with the New York Genome Center to help it sequence DNA for the treatment of brain cancer.
New York Genome will use IBM's "Jeopardy!" champion system to sequence the DNA of cancer tumors at much faster rate than would be possible if done by a human being.
Dr. Robert Darnell, the Genome Center's president, CEO and scientific director, says that once doctors know a tumor's genetic makeup, they can determine the best course of treatment for a particular patient.
Armonk, N.Y.-based IBM Corp. already has a partnership with Memorial Sloan-Kettering Cancer Center, where Watson is also used to help treat cancer.